BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 7087973)

  • 1. [Efficacy of oral hyposensitization treatment in house dust mite allergy (author's transl)].
    Urbanek R; Gehl R
    Monatsschr Kinderheilkd; 1982 Mar; 130(3):150-2. PubMed ID: 7087973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The evaluation of hyposensitization with house dust in patients with nasal allergy to house dust-mite].
    Ukai K; Amesara R; Masuda S; Nakamoto S; Ohkawa C; Okamoto K; Sakakura Y
    Arerugi; 1994 Jan; 43(1):16-21. PubMed ID: 8147704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].
    Zimmermann T; Mayer J
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):214-8. PubMed ID: 4000137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of mite asthma (author's transl)].
    Kirsten D
    Z Erkr Atmungsorgane; 1980; 155(1):120-4. PubMed ID: 7210736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal variability in nasal sensitivity to house dust mite extract.
    van Wijk RG; Dieges PH; van Toorenenbergen AW
    Rhinology; 1987 Mar; 25(1):41-8. PubMed ID: 3576060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [House dust mite allergy].
    Urbanek R; Behrle M; Kuhn W
    Padiatr Padol; 1991; 26(1):25-30. PubMed ID: 2057207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. House dust mite and house dust allergy.
    Collins-Williams ; Hung F; Keith Bremner K
    Ann Allergy; 1976 Jul; 37(1):12-7. PubMed ID: 782299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allergen-specific immunoglobulin E in the serum (RAST), skin tests and mucosa provocation tests using house dust and house mite extract in rhinopathy and bronchial asthma].
    Kleinhans D
    Fortschr Med; 1976 May; 94(14):815-20. PubMed ID: 1270045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and hyposensitization treatment of patients with house dust mite allergies in high mountain areas].
    Gühring H
    Z Hautkr; 1988; 63 Suppl 4():58-9. PubMed ID: 3252628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Considerations in diagnosis and therapy of house dust and house dust mites allergy (author's transl)].
    Schroeder-Ischka D
    Wien Klin Wochenschr Suppl; 1980; 117():27-8. PubMed ID: 6936979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
    Compalati E; Passalacqua G; Bonini M; Canonica GW
    Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
    Tari MG; Mancino M; Monti G
    Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
    Ebner H; Neuchrist C; Havelec L; Kraft D
    Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
    Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
    Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral hyposensitization of children with pollinosis or house-dust asthma.
    Wortmann F
    Allergol Immunopathol (Madr); 1977; 5(1):15-26. PubMed ID: 868717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.